Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Biora Therapeutics (BIOR)

Biora Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:BIOR
DateTimeSourceHeadlineSymbolCompany
30/12/202413:00GlobeNewswire Inc.Biora Therapeutics Undertakes Chapter 11 Sale Process to Position Business for Future GrowthNASDAQ:BIORBiora Therapeutics Inc
10/12/202412:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BIORBiora Therapeutics Inc
15/11/202421:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BIORBiora Therapeutics Inc
14/11/202413:00GlobeNewswire Inc.Biora Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial ResultsNASDAQ:BIORBiora Therapeutics Inc
07/11/202421:30GlobeNewswire Inc.Biora Therapeutics to Report Third Quarter 2024 Financial Results and Provide Corporate UpdateNASDAQ:BIORBiora Therapeutics Inc
29/10/202420:43Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BIORBiora Therapeutics Inc
29/10/202412:37Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:BIORBiora Therapeutics Inc
29/10/202412:28Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:BIORBiora Therapeutics Inc
29/10/202412:24Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:BIORBiora Therapeutics Inc
29/10/202412:21Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:BIORBiora Therapeutics Inc
29/10/202412:19Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:BIORBiora Therapeutics Inc
29/10/202412:15Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:BIORBiora Therapeutics Inc
29/10/202412:00GlobeNewswire Inc.Biora Therapeutics Announces $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesNASDAQ:BIORBiora Therapeutics Inc
28/10/202412:00GlobeNewswire Inc.Biora Therapeutics Shares Progress on Smaller BioJetâ„¢ Clinical Device with Largest Payload of any Ingestible Injectable at the 14th Annual PODD MeetingNASDAQ:BIORBiora Therapeutics Inc
23/10/202421:24Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:BIORBiora Therapeutics Inc
14/10/202412:00GlobeNewswire Inc.Biora Therapeutics to Reveal 00-Size BioJetâ„¢ Device at the 14th Annual Partnership Opportunities in Drug Delivery MeetingNASDAQ:BIORBiora Therapeutics Inc
11/10/202420:52Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:BIORBiora Therapeutics Inc
11/10/202412:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BIORBiora Therapeutics Inc
09/10/202421:40Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:BIORBiora Therapeutics Inc
07/10/202412:00GlobeNewswire Inc.Biora Therapeutics to Present at the 19th Annual Peptide Therapeutics SymposiumNASDAQ:BIORBiora Therapeutics Inc
30/09/202412:00GlobeNewswire Inc.Biora Therapeutics Announces Award-Winning Abstract to be Presented at American College of Gastroenterology Annual Scientific Meeting 2024NASDAQ:BIORBiora Therapeutics Inc
16/09/202420:30Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:BIORBiora Therapeutics Inc
13/09/202420:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BIORBiora Therapeutics Inc
13/09/202414:37Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:BIORBiora Therapeutics Inc
09/09/202412:00GlobeNewswire Inc.Biora Therapeutics Achieves ISO 13485 CertificationNASDAQ:BIORBiora Therapeutics Inc
05/09/202410:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BIORBiora Therapeutics Inc
04/09/202404:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:BIORBiora Therapeutics Inc
03/09/202420:31Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:BIORBiora Therapeutics Inc
28/08/202412:00GlobeNewswire Inc.Biora Therapeutics Announces Positive Nasdaq Listing DecisionNASDAQ:BIORBiora Therapeutics Inc
26/08/202412:00GlobeNewswire Inc.Biora Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:BIORBiora Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:BIOR